Peter Scheu
Plus aucun poste en cours
Fortune : 1 176 $ au 30/04/2024
Profil
Peter Scheu served as President of North American Commercial Operations at Alere, Inc. from 2007 to 2016.
He also served as President of Clinical Diagnostics at Apogent Technologies, Inc. and Vice President at Abbott Rapid Dx North America LLC.
From 2004 to 2006, he was President of Anatomic Pathology at Thermo Fisher Scientific, Inc. Currently, he is serving as President of North American Commercial Operations at LumiraDx Ltd.
(Cayman Islands) and LumiraDX Ltd.
Mr. Scheu completed his undergraduate degree from Miami University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
LUMIRADX LIMITED
0,03% | 31/12/2022 | 55 188 ( 0,03% ) | 1 104 $ | 30/04/2024 |
LUMIRADX LIMITED
0,00% | 31/12/2022 | 3 591 ( 0,00% ) | 72 $ | 30/04/2024 |
Anciens postes connus de Peter Scheu
Sociétés | Poste | Fin |
---|---|---|
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | Corporate Officer/Principal | 01/08/2023 |
LUMIRADX LIMITED | Corporate Officer/Principal | 01/08/2023 |
ALERE INC | Corporate Officer/Principal | 01/01/2016 |
THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | 01/01/2006 |
Apogent Technologies, Inc.
Apogent Technologies, Inc. Medical SpecialtiesHealth Technology Apogent Technologies, Inc. used to design and manufacture laboratory equipment. It was also developer and manufacturer of value-added products for the clinical and research markets. Apogent's operating subsidiaries were manufactures most of their products in approximately 80 facilities worldwide. It sells its goods primarily through distributors, but also directly to end users in the industrial, clinical and research markets. The company was located in Portsmouth, NH. | Corporate Officer/Principal | - |
Formation de Peter Scheu
Miami University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
LUMIRADX LIMITED | Health Technology |
THERMO FISHER SCIENTIFIC | Health Technology |
Entreprise privées | 4 |
---|---|
Abbott Rapid Dx North America LLC
Abbott Rapid Dx North America LLC Medical SpecialtiesHealth Technology Abbott Rapid Dx North America LLC develops and distributes advanced diagnostic devices. Its testing options include autoimmune disease, infectious and enteric diseases, sexually transmitted diseases, bladder cancer, and cardiac risk. The company is headquartered in Orlando, FL. | Health Technology |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | Health Technology |
Alere, Inc.
Alere, Inc. Medical SpecialtiesHealth Technology Alere, Inc. engages in developing, manufacturing, and marketing consumer and professional medical diagnostic products. It operates through the following segments: Professional Diagnostics, Consumer Diagnostics, and Other Non-Reportable. The Professional Diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests. The Consumer Diagnostics segment consists of manufacturing operations. The Other Non-Reportable segment includes Alere Home Monitoring, which distributes PT and INR coagulation; monitors and facilitates the distribution of equipment; and supplies to power and control customers' implanted ventricular assist devices and VADs. It also provides telemonitoring services that allow VAD coordinators to monitor patients soon after discharge and receive alerts when critical patient values fall outside pre-established ranges. The company was founded by Ronald Zwanziger on May 11, 2001 and is headquartered in Abbott Park, IL. | Health Technology |
Apogent Technologies, Inc.
Apogent Technologies, Inc. Medical SpecialtiesHealth Technology Apogent Technologies, Inc. used to design and manufacture laboratory equipment. It was also developer and manufacturer of value-added products for the clinical and research markets. Apogent's operating subsidiaries were manufactures most of their products in approximately 80 facilities worldwide. It sells its goods primarily through distributors, but also directly to end users in the industrial, clinical and research markets. The company was located in Portsmouth, NH. | Health Technology |